1. Home
  2. LGND vs SIMO Comparison

LGND vs SIMO Comparison

Compare LGND & SIMO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • LGND
  • SIMO
  • Stock Information
  • Founded
  • LGND 1987
  • SIMO 1995
  • Country
  • LGND United States
  • SIMO Hong Kong
  • Employees
  • LGND 68
  • SIMO N/A
  • Industry
  • LGND Biotechnology: Pharmaceutical Preparations
  • SIMO Semiconductors
  • Sector
  • LGND Health Care
  • SIMO Technology
  • Exchange
  • LGND Nasdaq
  • SIMO Nasdaq
  • Market Cap
  • LGND 2.2B
  • SIMO 2.6B
  • IPO Year
  • LGND 1992
  • SIMO 2005
  • Fundamental
  • Price
  • LGND $163.73
  • SIMO $79.80
  • Analyst Decision
  • LGND Strong Buy
  • SIMO Strong Buy
  • Analyst Count
  • LGND 8
  • SIMO 8
  • Target Price
  • LGND $144.71
  • SIMO $84.38
  • AVG Volume (30 Days)
  • LGND 139.7K
  • SIMO 231.1K
  • Earning Date
  • LGND 08-05-2025
  • SIMO 10-29-2025
  • Dividend Yield
  • LGND N/A
  • SIMO 2.52%
  • EPS Growth
  • LGND N/A
  • SIMO N/A
  • EPS
  • LGND N/A
  • SIMO 2.30
  • Revenue
  • LGND $181,488,000.00
  • SIMO $768,738,000.00
  • Revenue This Year
  • LGND $18.41
  • SIMO $5.44
  • Revenue Next Year
  • LGND $18.87
  • SIMO $15.56
  • P/E Ratio
  • LGND N/A
  • SIMO $34.64
  • Revenue Growth
  • LGND 53.40
  • SIMO N/A
  • 52 Week Low
  • LGND $81.74
  • SIMO $37.21
  • 52 Week High
  • LGND $129.90
  • SIMO $85.11
  • Technical
  • Relative Strength Index (RSI)
  • LGND 74.67
  • SIMO 59.01
  • Support Level
  • LGND $158.40
  • SIMO $71.35
  • Resistance Level
  • LGND $161.89
  • SIMO $83.00
  • Average True Range (ATR)
  • LGND 3.76
  • SIMO 2.58
  • MACD
  • LGND -0.07
  • SIMO 0.41
  • Stochastic Oscillator
  • LGND 93.80
  • SIMO 72.53

About LGND Ligand Pharmaceuticals Incorporated

Ligand Pharmaceuticals Inc is a biopharmaceutical company focused on developing and acquiring technologies that aid in creating medicine. The company has partnerships and license agreements with various pharmaceutical and biotechnology companies. Ligand's business model is based on drug discovery, early-stage drug development, product reformulation, and partnerships. The company's revenue consists of three primary elements: royalties from commercialized products, license and milestone payments, and sale of its trademarked Captisol material.

About SIMO Silicon Motion Technology Corporation

Silicon Motion Technology Corp is engaged in developing NAND flash controllers for SSDs and other solid state storage devices. Its only operating segment is to develop NAND flash controllers and SSDs solutions. The company derives revenue from product categories such as Mobile Storage, Mobile Communications, and others. Silicon's geographical segments are Taiwan, the United States, Korea, China, Singapore, Malaysia, and others. The company products are used in Personal Computing, Smartphone/Tablet/CE, Flash Card/USB Flash Drive, Industrial and Embedded, Automotive, and Enterprise and Data centers.

Share on Social Networks: